| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Retinoate measurement (procedure) |
Component |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Retinoate ester measurement |
Component |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
2 |
| Tretinoin adverse reaction |
Causative agent (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin overdose |
Causative agent (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Accidental tretinoin overdose |
Causative agent (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Intentional tretinoin overdose |
Causative agent (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| surdose de trétinoïne d'intention indéterminée |
Causative agent (attribute) |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin [cytostatic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Tretinoin 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Tretinoin [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Tretinoin 250 microgram/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Tretinoin 100 microgram/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Tretinoin 500 microgram/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Tretinoin 250 microgram/g cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| embryopathie causée par l'acide rétinoïque |
Causative agent (attribute) |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Tretinoin 0.05% liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely tretinoin 200 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Tretinoin 1 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Tretinoin 1 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely mequinol 20 milligram/1 milliliter and tretinoin 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Product containing tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing mequinol and tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing erythromycin and tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
2 |
| Tretinoin 400 microgram/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Product containing fluocinolone acetonide and hydroquinone and tretinoin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Fluocinolone acetonide 100 microgram/mL and hydroquinone 40 mg/mL and tretinoin 500 microgram/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Allergy to tretinoin (finding) |
Causative agent (attribute) |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Product containing clindamycin and tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
2 |
| Clindamycin 1.2%/tretinoin 0.025% topical gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Isotretinoin (substance) |
Is a |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| syndrome de l'acide rétinoïque de la leucémie promyélocytaire aiguë |
Causative agent (attribute) |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Product containing tretinoin in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Tretinoin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Retinoic acid syndrome |
Causative agent (attribute) |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
|
| Allergy to tretinoin (finding) |
Causative agent (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin 10 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin 10 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin 250 microgram/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin 250 microgram/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin 100 microgram/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin 100 microgram/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin 500 microgram/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin 500 microgram/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin 250 microgram/g cutaneous lotion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin 250 microgram/g cutaneous lotion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing fluocinolone and hydroquinone and tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing tretinoin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing erythromycin and tretinoin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
2 |
| Product containing only clindamycin and tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
2 |
| Erythromycin and tretinoin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
2 |
| Fluocinolone and hydroquinone and tretinoin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only mequinol and tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Erythromycin and tretinoin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
2 |
| Tretinoin 400 microgram/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin 400 microgram/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin 1 mg/mL cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin 1 mg/mL cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tretinoin 200 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tretinoin 200 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin 1 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin 1 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
2 |
| Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
2 |
| Tretinoin 500 microgram/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Tretinoin 500 microgram/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Fluocinolone acetonide 100 microgram/mL and hydroquinone 40 mg/mL and tretinoin 500 microgram/mL cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Fluocinolone acetonide 100 microgram/mL and hydroquinone 40 mg/mL and tretinoin 500 microgram/mL cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely mequinol 20 milligram/1 milliliter and tretinoin 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely mequinol 20 milligram/1 milliliter and tretinoin 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Mequinol and tretinoin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Fluocinolone and hydroquinone and tretinoin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing clindamycin and tretinoin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
2 |
| Fluocinolone- and hydroquinone- and tretinoin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing mequinol and tretinoin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
2 |
| Retinoate ester measurement |
Component |
True |
Tretinoin (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]